Patient Guide: Subretinal Delivery of Investigational Surabgene Lomparvovec (Sura-vec; ABBV-RGX-314) for Neovascular AMD: A Phase II Pharmacodynamic Study: 1-year Results

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at multiple participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTABBV-RGX-314
Status: COMPLETED
Condition: Neovascular AMD
Phase: PHASE2

Loading interactive enrollment tools...

The full interactive experience will load momentarily